Correlation Between Rocket Pharmaceuticals and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rocket Pharmaceuticals and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rocket Pharmaceuticals and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rocket Pharmaceuticals and AN2 Therapeutics, you can compare the effects of market volatilities on Rocket Pharmaceuticals and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rocket Pharmaceuticals with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rocket Pharmaceuticals and AN2 Therapeutics.
Diversification Opportunities for Rocket Pharmaceuticals and AN2 Therapeutics
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rocket and AN2 is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Rocket Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rocket Pharmaceuticals are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Rocket Pharmaceuticals i.e., Rocket Pharmaceuticals and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Rocket Pharmaceuticals and AN2 Therapeutics
Given the investment horizon of 90 days Rocket Pharmaceuticals is expected to under-perform the AN2 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Rocket Pharmaceuticals is 1.79 times less risky than AN2 Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The AN2 Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 723.00 in AN2 Therapeutics on September 2, 2024 and sell it today you would lose (556.00) from holding AN2 Therapeutics or give up 76.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rocket Pharmaceuticals vs. AN2 Therapeutics
Performance |
| Timeline |
| Rocket Pharmaceuticals |
| AN2 Therapeutics |
Rocket Pharmaceuticals and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rocket Pharmaceuticals and AN2 Therapeutics
The main advantage of trading using opposite Rocket Pharmaceuticals and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rocket Pharmaceuticals position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Rocket Pharmaceuticals vs. Uniqure NV | Rocket Pharmaceuticals vs. Rhythm Pharmaceuticals | Rocket Pharmaceuticals vs. Solid Biosciences LLC | Rocket Pharmaceuticals vs. MeiraGTx Holdings PLC |
| AN2 Therapeutics vs. Tff Pharmaceuticals | AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Inhibrx | AN2 Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |